{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T15:53:29Z","timestamp":1772812409215,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.clinbiochem.2018.05.006","type":"journal-article","created":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T12:32:00Z","timestamp":1525782720000},"page":"53-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["The potential role of a turbidimetric heart-type fatty acid-binding protein assay to aid in the interpretation of persistently elevated, non-changing, cardiac troponin I concentrations"],"prefix":"10.1016","volume":"58","author":[{"given":"Peter A.","family":"Kavsak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig","family":"Ainsworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald M.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terry","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorna","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josko","family":"Ivica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharine","family":"Mackett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Whitlock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Worster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2018.05.006_bb0005","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","volume":"37","author":"Roffi","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.clinbiochem.2018.05.006_bb0010","article-title":"Macrocomplexes and discordant high-sensitivity cardiac troponin concentrations","volume":"1","author":"Kavsak","year":"2017","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.clinbiochem.2018.05.006_bb0015","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.clinbiochem.2015.01.008","article-title":"High-sensitive cardiac troponin, NT-proBNP, hFABP and copeptin levels in relation to glomerular filtration rates and a medical record of cardiovascular disease","volume":"48","author":"Bjurman","year":"2015","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.clinbiochem.2018.05.006_bb0020","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1161\/CIRCULATIONAHA.117.031717","article-title":"The cardiac troponin renal disease diagnostic conundrum: past, present, and future","volume":"137","author":"deFilippi","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2018.05.006_bb0025","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.cca.2018.01.034","article-title":"Performance of high-sensitivity cardiac troponin in the emergency department for myocardial infarction and a composite cardiac outcome across different estimated glomerular filtration rates","volume":"479","author":"Kavsak","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.clinbiochem.2018.05.006_bb0030","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1373\/clinchem.2017.277186","volume":"64","author":"Wu","year":"2018","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2018.05.006_bb0035","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1373\/clinchem.2010.144139","article-title":"The effect of sample hemolysis on cardiac troponin I and T assays","volume":"56","author":"Bais","year":"2010","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2018.05.006_bb0040","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cca.2015.01.002","article-title":"Matrix and bilirubin interference for high-sensitivity cardiac troponin I","volume":"442","author":"Simons","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.clinbiochem.2018.05.006_bb0045","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/ajcp\/aqx066","article-title":"Variability and error in cardiac troponin testing: an ACLPS critical review","volume":"148","author":"Herman","year":"2017","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.clinbiochem.2018.05.006_bb0050","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1515\/cclm-2016-0455","article-title":"Interference of laboratory disinfection with trichloro-isocyanuric acid on cardiac troponin I measurement using the Vitros immunoassay system","volume":"55","author":"Zhao","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2018.05.006_bb0055","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1515\/cclm-2017-0350","article-title":"Analytical evaluation of the new Beckman Coulter Access high sensitivity cardiac troponin I immunoassay","volume":"56","author":"Lippi","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2018.05.006_bb0060","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1515\/cclm-2017-0387","article-title":"Evaluation of analytical performance of a new high-sensitivity immunoassay for cardiac troponin I","volume":"56","author":"Masotti","year":"2018","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2018.05.006_bb0065","doi-asserted-by":"crossref","DOI":"10.1515\/cclm-2017-1122","article-title":"Assessing matrix, interferences and comparability between the Abbott Diagnostics and the Beckman Coulter high-sensitivity cardiac troponin I assays","author":"Kavsak","year":"2018","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2018.05.006_bb0070","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1001\/jamainternmed.2017.3597","article-title":"Eliminating creatine kinase-myocardial band testing in suspected acute coronary syndrome: a value-based quality improvement","volume":"177","author":"Alvin","year":"2017","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.clinbiochem.2018.05.006_bb0075","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1213\/ANE.0b013e3181dd9516","article-title":"Heart-type fatty acid binding protein is an independent predictor of death and ventricular dysfunction after coronary artery bypass graft surgery","volume":"111","author":"Muehlschlegel","year":"2010","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.clinbiochem.2018.05.006_bb0080","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12872-016-0340-1","article-title":"The serum heart-type fatty acid-binding protein (HFABP) levels can be used to detect the presence of acute kidney injury on admission in patients admitted to the non-surgical intensive care unit","volume":"16","author":"Shirakabe","year":"2016","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.clinbiochem.2018.05.006_bb0085","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1471-2261-14-117","article-title":"Preoperative serum h-FABP concentration is associated with postoperative incidence of acute kidney injury in patients undergoing cardiac surgery","volume":"14","author":"Oezkur","year":"2014","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.clinbiochem.2018.05.006_bb0090","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/ki.2015.104","article-title":"Perioperative heart-type fatty acid binding protein is associated with acute kidney injury after cardiac surgery","volume":"88","author":"Schaub","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.clinbiochem.2018.05.006_bb0095","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1681\/ASN.2017010055","article-title":"Relationship of kidney injury biomarkers with long-term cardiovascular outcomes after cardiac surgery","volume":"28","author":"Parikh","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.clinbiochem.2018.05.006_bb0100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40364-018-0117-z","article-title":"Development of biomarker combinations for postoperative acute kidney injury via Bayesian model selection in a multicenter cohort study","volume":"6","author":"Meisner","year":"2018","journal-title":"Biomarker Res."},{"key":"10.1016\/j.clinbiochem.2018.05.006_bb0105","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrd2589","article-title":"Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets","volume":"7","author":"Furuhashi","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.clinbiochem.2018.05.006_bb0110","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cca.2017.09.007","article-title":"Heart-type fatty acid-binding protein in cardiovascular disease: a systemic review","volume":"474","author":"Otaki","year":"2017","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.clinbiochem.2018.05.006_bb0115","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2217\/clp.13.87","article-title":"Added value of H-FABP as a plasma biomarker for the early evaluation of suspected acute coronary syndrome","volume":"9","author":"Glatz","year":"2014","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.clinbiochem.2018.05.006_bb0120","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/emermed-2014-204235","article-title":"The Manchester Acute Coronary Syndromes (MACS) decision rule: validation with a new automated assay for heart-type fatty acid binding protein","volume":"32","author":"Body","year":"2015","journal-title":"Emerg. Med. J."},{"key":"10.1016\/j.clinbiochem.2018.05.006_bb0125","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.clinbiochem.2012.10.016","article-title":"Critical review and meta-analysis on the combination of heart-type fatty acid binding protein (H-FABP) and troponin for early diagnosis of acute myocardial infarction","volume":"46","author":"Lippi","year":"2013","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.clinbiochem.2018.05.006_bb0130","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1093\/eurheartj\/ehs154","article-title":"How to use high-sensitivity cardiac troponins in acute cardiac care","volume":"33","author":"Thygesen","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.clinbiochem.2018.05.006_bb0135","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.cca.2013.11.012","article-title":"Analytical factors to consider when assessing a high-sensitivity cardiac troponin I assay compared to a contemporary assay in clinical studies","volume":"429","author":"Rezvanpour","year":"2014","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.clinbiochem.2018.05.006_bb0140","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1373\/clinchem.2005.059550","article-title":"Assessing the requirement for the 6-hour interval between specimens in the American Heart Association Classification of Myocardial Infarction in Epidemiology and Clinical Research Studies","volume":"52","author":"Macrae","year":"2006","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2018.05.006_bb0145","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ahj.2005.09.022","article-title":"The impact of the ESC\/ACC redefinition of myocardial infarction and new sensitive troponin assays on the frequency of acute myocardial infarction","volume":"152","author":"Kavsak","year":"2006","journal-title":"Am. Heart J."},{"key":"10.1016\/j.clinbiochem.2018.05.006_bb0150","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1161\/CIRCULATIONAHA.107.187397","article-title":"Universal definition of myocardial infarction","volume":"116","author":"Thygesen","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2018.05.006_bb0155","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1373\/clinchem.2009.136689","article-title":"2007 universal myocardial infarction definition change criteria for risk stratification by use of a high-sensitivity cardiac troponin I assay","volume":"56","author":"Kavsak","year":"2010","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2018.05.006_bb0160","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1373\/clinchem.2011.174755","article-title":"High-sensitivity cardiac troponin assays\u2013change is important","volume":"58","author":"Kavsak","year":"2012","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2018.05.006_bb0165","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1136\/heartjnl-2015-308505","article-title":"Validation of presentation and 3\u202fh high-sensitivity troponin to rule-in and rule-out acute myocardial infarction","volume":"102","author":"Pickering","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.clinbiochem.2018.05.006_bb0170","first-page":"1657","article-title":"European multicenter analytical evaluation of the Abbott ARCHITECT STAT high sensitive troponin I immunoassay","volume":"52","author":"Krintus","year":"2014","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2018.05.006_bb0175","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1373\/clinchem.2016.255448","article-title":"Acceptable analytical variation may exceed high-sensitivity cardiac troponin I cutoffs in early rule-out and rule-in acute myocardial infarction algorithms","volume":"62","author":"Kavsak","year":"2016","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2018.05.006_bb0180","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1373\/clinchem.2006.084194","article-title":"National Academy of Clinical Biochemistry practice guidelines: clinical characteristics and utilization of biomarkers in acute coronary syndromes","volume":"53","author":"Morrow","year":"2007","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2018.05.006_bb0185","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1515\/cclm-2015-1276","article-title":"High incidence of macrotroponin I with a high-sensitivity troponin I assay","volume":"54","author":"Warner","year":"2016","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2018.05.006_bb0190","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.clinbiochem.2017.10.001","article-title":"External validation of heart-type fatty acid binding protein, high-sensitivity cardiac troponin, and electrocardiography as rule-out for acute myocardial infarction","volume":"52","author":"Van Hise","year":"2018","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.clinbiochem.2018.05.006_bb0195","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1161\/CIR.0b013e31826e1058","article-title":"Third universal definition of myocardial infarction","volume":"126","author":"Thygesen","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2018.05.006_bb0200","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1136\/heartjnl-2012-301635","article-title":"The prognostic value of high sensitivity troponin T 7 weeks after an acute coronary syndrome","volume":"98","author":"Ang","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.clinbiochem.2018.05.006_bb0205","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1373\/clinchem.2012.196071","article-title":"Persistent increases in cardiac troponin concentrations as measured with high-sensitivity assays after acute myocardial infarction","volume":"59","author":"Sievenpiper","year":"2013","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2018.05.006_bb0210","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cca.2017.10.006","article-title":"Analytical comparison of three different versions of a high-sensitivity cardiac troponin I assay over 10\u202fyears","volume":"475","author":"Kavsak","year":"2017","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.clinbiochem.2018.05.006_bb0215","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1515\/cclm-2016-0091","article-title":"Criteria for assigning laboratory measurands to models for analytical performance specifications defined in the 1st EFLM Strategic Conference","volume":"55","author":"Ceriotti","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2018.05.006_bb0220","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.jacc.2011.08.026","article-title":"Diseased skeletal muscle: a noncardiac source of increased circulating concentrations of cardiac troponin T","volume":"58","author":"Jaffe","year":"2011","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000991201830362X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000991201830362X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:52:50Z","timestamp":1757865170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000991201830362X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":44,"alternative-id":["S000991201830362X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2018.05.006","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The potential role of a turbidimetric heart-type fatty acid-binding protein assay to aid in the interpretation of persistently elevated, non-changing, cardiac troponin I concentrations","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2018.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc. on behalf of The Canadian Society of Clinical Chemists.","name":"copyright","label":"Copyright"}]}}